O'Donnell JS - Search Results

1

Characterization and comparison of novel adjuvants for a prefusion clamped MERS vaccine.

O'Donnell JS, Isaacs A, Jakob V, Lebas C, Barnes JB, Reading PC, Young PR, Watterson D, Dubois PM, Collin N, Chappell KJ. O'Donnell JS, et al. Front Immunol. 2022 Sep 2;13:976968. doi: 10.3389/fimmu.2022.976968. eCollection 2022. Front Immunol. 2022. PMID: 36119058 Free PMC article.

2

Chronic SARS-CoV-2, a Cause of Post-acute COVID-19 Sequelae (Long-COVID)?

O'Donnell JS, Chappell KJ. O'Donnell JS, et al. Front Microbiol. 2021 Aug 2;12:724654. doi: 10.3389/fmicb.2021.724654. eCollection 2021. Front Microbiol. 2021. PMID: 34408742 Free PMC article.

3

Integrated molecular and immunological features of human T-lymphotropic virus type 1 infection and disease progression to adult T-cell leukaemia or lymphoma.

O'Donnell JS, Hunt SK, Chappell KJ. O'Donnell JS, et al. Lancet Haematol. 2023 Jul;10(7):e539-e548. doi: 10.1016/S2352-3026(23)00087-X. Lancet Haematol. 2023. PMID: 37407143 Review.

4

HTLV-1 reverse transcriptase homology model provides structural basis for sensitivity to existing nucleoside/nucleotide reverse transcriptase inhibitors.

Tardiota N, Jaberolansar N, Lackenby JA, Chappell KJ, O'Donnell JS. Tardiota N, et al. Among authors: o donnell js. Virol J. 2024 Jan 10;21(1):14. doi: 10.1186/s12985-024-02288-z. Virol J. 2024. PMID: 38200531 Free PMC article.

5

Human T-lymphotropic virus type 1 and antiretroviral therapy: practical considerations for pre-exposure and post-exposure prophylaxis, transmission prevention, and mitigation of severe disease.

O'Donnell JS, Jaberolansar N, Chappell KJ. O'Donnell JS, et al. Lancet Microbe. 2024 Apr;5(4):e400-e408. doi: 10.1016/S2666-5247(23)00359-2. Epub 2024 Jan 18. Lancet Microbe. 2024. PMID: 38246188 Free article. Review.

6

PD1 functions by inhibiting CD28-mediated co-stimulation.

O'Donnell JS, Smyth MJ, Teng MWL. O'Donnell JS, et al. Clin Transl Immunology. 2017 May 5;6(5):e138. doi: 10.1038/cti.2017.15. eCollection 2017 May. Clin Transl Immunology. 2017. PMID: 28690844 Free PMC article. No abstract available.

7

The voltage gated Ca(2+)-channel Cav3.2 and therapeutic responses in breast cancer.

Pera E, Kaemmerer E, Milevskiy MJG, Yapa KTDS, O'Donnell JS, Brown MA, Simpson F, Peters AA, Roberts-Thomson SJ, Monteith GR. Pera E, et al. Cancer Cell Int. 2016 Mar 31;16:24. doi: 10.1186/s12935-016-0299-0. eCollection 2016. Cancer Cell Int. 2016. PMID: 27034617 Free PMC article.

8

RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancer.

Ahern E, Harjunpää H, O'Donnell JS, Allen S, Dougall WC, Teng MWL, Smyth MJ. Ahern E, et al. Oncoimmunology. 2018 Feb 14;7(6):e1431088. doi: 10.1080/2162402X.2018.1431088. eCollection 2018. Oncoimmunology. 2018. PMID: 29872559 Free PMC article.

9

Batf3⁺ DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapy.

Liu J, Rozeman EA, O'Donnell JS, Allen S, Fanchi L, Smyth MJ, Blank CU, Teng MWL. Liu J, et al. Oncoimmunology. 2018 Nov 22;8(2):e1546068. doi: 10.1080/2162402X.2018.1546068. eCollection 2019. Oncoimmunology. 2018. PMID: 30713806 Free PMC article.

10

Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies.

Chew HY, De Lima PO, Gonzalez Cruz JL, Banushi B, Echejoh G, Hu L, Joseph SR, Lum B, Rae J, O'Donnell JS, Merida de Long L, Okano S, King B, Barry R, Moi D, Mazzieri R, Thomas R, Souza-Fonseca-Guimaraes F, Foote M, McCluskey A, Robinson PJ, Frazer IH, Saunders NA, Parton RG, Dolcetti R, Cuff K, Martin JH, Panizza B, Walpole E, Wells JW, Simpson F. Chew HY, et al. Cell. 2020 Mar 5;180(5):895-914.e27. doi: 10.1016/j.cell.2020.02.019. Cell. 2020. PMID: 32142680 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

196 results

Search Page